Search filters

List of works by Elizabeth K Wansley

Apoptosis induction and interferon signaling but not IFN-beta promoter induction by an SV5 P/V mutant are rescued by coinfection with wild-type SV5.

scientific article published on November 2003

Combination therapy of an orthotopic renal cell carcinoma model using intratumoral vector-mediated costimulation and systemic interleukin-2.

scientific article published in March 2007

Controlled cell killing by a recombinant nonsegmented negative-strand RNA virus.

scientific article published on February 2002

Exchange of P/V genes between two non-cytopathic simian virus 5 variants results in a recombinant virus that kills cells through death pathways that are sensitive to caspase inhibitors.

scientific article published on December 2006

Growth sensitivity of a recombinant simian virus 5 P/V mutant to type I interferon differs between tumor cell lines and normal primary cells.

scientific article

Intratumoral delivery of vector mediated IL-2 in combination with vaccine results in enhanced T cell avidity and anti-tumor activity

scientific article published on 15 May 2007

Multi-functional cytotoxic T cell expansion correlates with overall survival after administration of autologous dendritic cell immunotherapy in renal cell cancer patients

scientific article published on 7 November 2013

Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death

scientific article published on October 2002

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

scientific article published on 24 April 2006

Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells

scientific article published on 03 December 2007

Synergistic antitumor activity of immune strategies combined with radiation.

scientific article published on September 2007

Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses.

scientific article published on July 2008